Literature DB >> 21253124

Intravenous IgG: A New Therapeutic Tool.

L K Boshkov, J G Kelton.   

Abstract

Since the 1950s, intramuscular gammaglobulin preparations have been used for antibody replacement in patients with immune deficiency syndromes. The authors of this article discuss newer intravenous formulations which have expanded the role of IgG preparations from simple antibody replacement to therapeutic use in high doses as an immune suppressant and an autoimmune modulator.

Entities:  

Year:  1988        PMID： 21253124      PMCID： PMC2219018     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  36 in total

1.  Immune thrombocytopenia gammaglobulin, and positivity to the human T-lymphotropic virus type III.

Authors:  Y Laurian; P Le Bras; A Ellrodt; P Alvin
Journal:  Ann Intern Med       Date:  1986-07       Impact factor: 25.391

Review 2.  Intravenous treatment with gammaglobulin in adults with immune thrombocytopenic purpura: review of the literature.

Authors:  J B Bussel; L C Pham
Journal:  Vox Sang       Date:  1987       Impact factor: 2.144

3.  I.v. immune globulin: efficacy and safety.

Authors:  A B Minnefor; J M Oleske
Journal:  Hosp Pract (Off Ed)       Date:  1987-10-15

4.  Dose of intravenous IgG in primary hypogammaglobulinaemia.

Authors:  P E Williams; P L Yap; D B McClelland
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

5.  Subcutaneous immunoglobulin home treatment in hypogammaglobulinaemia.

Authors:  M F Leahy
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321

6.  Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients.

Authors:  R K Woodruff; A P Grigg; F C Firkin; I L Smith
Journal:  Lancet       Date:  1986-07-26       Impact factor: 79.321

7.  Hemolysis following intravenous immune globulin therapy.

Authors:  E A Copelan; P L Strohm; M S Kennedy; P J Tutschka
Journal:  Transfusion       Date:  1986 Sep-Oct       Impact factor: 3.157

8.  Intravenous immune serum globulin in immune thrombocytopenia: clinical results and biochemical evaluation.

Authors:  J Bussel
Journal:  Vox Sang       Date:  1985       Impact factor: 2.144

Review 9.  Intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura in childhood and adolescence.

Authors:  J B Bussel; M W Hilgartner
Journal:  Hematol Oncol Clin North Am       Date:  1987-09       Impact factor: 3.722

10.  Studies on bacteriemia. V. The effect of simultaneous leukopenia and reticuloendothelial blockade on the early blood stream clearance of staphylococci and Escherichia coli.

Authors:  B M DERBY; D E ROGERS
Journal:  J Exp Med       Date:  1961-06-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.